Insider sale
TAYSHA GENE THERAPIES, INC.
$158.7K
33.74K shares
What this filing means
HAQUE-AHMED RUMANA plans to sell 33.74K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $158.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2026ACC: 0002086827-26-000008
33.74K
Shares to sell
$158.7K
Approx. market value
2.40K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
2/27/2026
2.40KTotal acquired2.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/27/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 2.40K | — |
| Total | 2.40K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
697.00
Market value
$3.2K
2/4/2026
—Completed
Units to sell
7.11K
Market value
$32.8K
1/26/2026
—Completed
Units to sell
23.53K
Market value
$111.8K
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.40K
Market value
$11.0K
2/27/2026
Total
Units
33.74K
Value
$158.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 697.00 | $3.2K | — | Completed |
1/26/2026 | 7.11K | $32.8K | — | Completed |
1/23/2026 | 23.53K | $111.8K | — | Completed |
| Planned — Approximate Date | ||||
2/27/2026 | 2.40K | $11.0K | Nasdaq | Planned |
| Total | 33.74K | $158.7K | ||